Phacoemulsification plus endoscopic cyclophotocoagulation versus phacoemulsification alone in primary open-angle glaucoma

Phacoemulsification plus endoscopic cyclophotocoagulation versus phacoemulsification alone in primary open-angle glaucoma

Purpose: To examine the efficacy and safety of combined phacoemulsification and endoscopic cyclophotocoagulation (phaco-ECP) compared to phacoemulsification alone in patients with primary open-angle glaucoma (POAG). Methods: We performed a retrospective notes review of 99 consecutive clinical record...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of ophthalmology 2018-03, Vol.28 (2), p.168-174
Hauptverfasser: Pérez Bartolomé, Francisco, Rodrigues, Ian A., Goyal, Saurabh, Bloch, Edward, Lim, Wei S., Alaghband, Pouya, Guajardo, Jose, Jones, Stephanie, Lim, Kin S.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 174
container_issue 2
container_start_page 168
container_title European journal of ophthalmology
container_volume 28
creator Pérez Bartolomé, Francisco
Rodrigues, Ian A.
Goyal, Saurabh
Bloch, Edward
Lim, Wei S.
Alaghband, Pouya
Guajardo, Jose
Jones, Stephanie
Lim, Kin S.
description Purpose: To examine the efficacy and safety of combined phacoemulsification and endoscopic cyclophotocoagulation (phaco-ECP) compared to phacoemulsification alone in patients with primary open-angle glaucoma (POAG). Methods: We performed a retrospective notes review of 99 consecutive clinical records of patients with POAG from 2 London eye departments. A total of 69 patients who underwent phaco-ECP and 30 sex- and age-matched control patients who underwent cataract surgery alone were included. Data on intraocular pressure (IOP), visual acuity (VA), number of ocular hypotensive medications, and postoperative complications were collected over 12 months. The primary outcome measure was defined as an IOP within normal limits (
doi_str_mv 10.5301/ejo.5001034
format Article
fullrecord <record><control><sourceid>sage_cross</sourceid><recordid>TN_cdi_crossref_primary_10_5301_ejo_5001034</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.5301_ejo.5001034</sage_id><sourcerecordid>10.5301_ejo.5001034</sourcerecordid><originalsourceid>FETCH-LOGICAL-c322t-c9e51871576f8af5f374d0c5d934f5ab20f1fbc4e7ba26eb932d3ef78ba4b77e3</originalsourceid><addsrcrecordid>eNptkM1LwzAYh4Mobk5P3qVHQTrz2bRHGfMDBnrQc0nSN11H2pRmFfbfG-n0tNP7Hh4efjwI3RK8FAyTR9j5pcCYYMbP0JxIytMMk-w8_oTiNJOUzNBVCDuMKS44vUQzWmApSU7n6PCxVcZDO7rQ2MaofeO7pHdjSKCrfDC-b0xiDsb5fuv33nhVj26ivmEIketPCJTzHSRNNA1Nq4ZD4nvoUtXVDpLaqdH4Vl2jC6tcgJvjXaCv5_Xn6jXdvL-8rZ42qWGU7lNTgCC5JEJmNldWWCZ5hY2oCsatUJpiS6w2HKRWNANdMFoxsDLXimspgS3Qw-Q1gw9hAFseR5UEl78ByxiwPAaM9N1E96Nuofpn_4pF4H4Cgqqh3Plx6OL6k64f41h9eQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Phacoemulsification plus endoscopic cyclophotocoagulation versus phacoemulsification alone in primary open-angle glaucoma</title><source>Access via SAGE</source><creator>Pérez Bartolomé, Francisco ; Rodrigues, Ian A. ; Goyal, Saurabh ; Bloch, Edward ; Lim, Wei S. ; Alaghband, Pouya ; Guajardo, Jose ; Jones, Stephanie ; Lim, Kin S.</creator><creatorcontrib>Pérez Bartolomé, Francisco ; Rodrigues, Ian A. ; Goyal, Saurabh ; Bloch, Edward ; Lim, Wei S. ; Alaghband, Pouya ; Guajardo, Jose ; Jones, Stephanie ; Lim, Kin S.</creatorcontrib><description>Purpose: To examine the efficacy and safety of combined phacoemulsification and endoscopic cyclophotocoagulation (phaco-ECP) compared to phacoemulsification alone in patients with primary open-angle glaucoma (POAG). Methods: We performed a retrospective notes review of 99 consecutive clinical records of patients with POAG from 2 London eye departments. A total of 69 patients who underwent phaco-ECP and 30 sex- and age-matched control patients who underwent cataract surgery alone were included. Data on intraocular pressure (IOP), visual acuity (VA), number of ocular hypotensive medications, and postoperative complications were collected over 12 months. The primary outcome measure was defined as an IOP within normal limits (&lt;21 mm Hg) and at least a 20% reduction in IOP from baseline. Results: Mean IOP was significantly decreased in both groups after 1 year (p&lt;0.001 from baseline). The success rate was significantly higher in the phaco-ECP group (69.6%) than in the phaco group (40%) after 1 year (p = 0.004). Reduction in mean IOP and number of medications was also greater in the phaco-ECP group after 1 year (IOP reduction: 4.5 ± 5.13 mm Hg vs 1.83 ± 3.61 mm Hg; p = 0.007; number of medications reduction: 0.73 ± 0.71 vs 0.23 ± 0.56; p = 0.001). Both groups achieved a similar improvement in VA. There was a higher incidence of minor and self-limiting complications in the phaco-ECP group (p&lt;0.047). Conclusions: Phaco-ECP resulted in a greater reduction in IOP and number of medications than phacoemulsification alone in POAG.</description><identifier>ISSN: 1120-6721</identifier><identifier>EISSN: 1724-6016</identifier><identifier>DOI: 10.5301/ejo.5001034</identifier><identifier>PMID: 29077182</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><ispartof>European journal of ophthalmology, 2018-03, Vol.28 (2), p.168-174</ispartof><rights>The Author(s) 2017</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c322t-c9e51871576f8af5f374d0c5d934f5ab20f1fbc4e7ba26eb932d3ef78ba4b77e3</citedby><cites>FETCH-LOGICAL-c322t-c9e51871576f8af5f374d0c5d934f5ab20f1fbc4e7ba26eb932d3ef78ba4b77e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.5301/ejo.5001034$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.5301/ejo.5001034$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,780,784,21819,27924,27925,43621,43622</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29077182$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pérez Bartolomé, Francisco</creatorcontrib><creatorcontrib>Rodrigues, Ian A.</creatorcontrib><creatorcontrib>Goyal, Saurabh</creatorcontrib><creatorcontrib>Bloch, Edward</creatorcontrib><creatorcontrib>Lim, Wei S.</creatorcontrib><creatorcontrib>Alaghband, Pouya</creatorcontrib><creatorcontrib>Guajardo, Jose</creatorcontrib><creatorcontrib>Jones, Stephanie</creatorcontrib><creatorcontrib>Lim, Kin S.</creatorcontrib><title>Phacoemulsification plus endoscopic cyclophotocoagulation versus phacoemulsification alone in primary open-angle glaucoma</title><title>European journal of ophthalmology</title><addtitle>Eur J Ophthalmol</addtitle><description>Purpose: To examine the efficacy and safety of combined phacoemulsification and endoscopic cyclophotocoagulation (phaco-ECP) compared to phacoemulsification alone in patients with primary open-angle glaucoma (POAG). Methods: We performed a retrospective notes review of 99 consecutive clinical records of patients with POAG from 2 London eye departments. A total of 69 patients who underwent phaco-ECP and 30 sex- and age-matched control patients who underwent cataract surgery alone were included. Data on intraocular pressure (IOP), visual acuity (VA), number of ocular hypotensive medications, and postoperative complications were collected over 12 months. The primary outcome measure was defined as an IOP within normal limits (&lt;21 mm Hg) and at least a 20% reduction in IOP from baseline. Results: Mean IOP was significantly decreased in both groups after 1 year (p&lt;0.001 from baseline). The success rate was significantly higher in the phaco-ECP group (69.6%) than in the phaco group (40%) after 1 year (p = 0.004). Reduction in mean IOP and number of medications was also greater in the phaco-ECP group after 1 year (IOP reduction: 4.5 ± 5.13 mm Hg vs 1.83 ± 3.61 mm Hg; p = 0.007; number of medications reduction: 0.73 ± 0.71 vs 0.23 ± 0.56; p = 0.001). Both groups achieved a similar improvement in VA. There was a higher incidence of minor and self-limiting complications in the phaco-ECP group (p&lt;0.047). Conclusions: Phaco-ECP resulted in a greater reduction in IOP and number of medications than phacoemulsification alone in POAG.</description><issn>1120-6721</issn><issn>1724-6016</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNptkM1LwzAYh4Mobk5P3qVHQTrz2bRHGfMDBnrQc0nSN11H2pRmFfbfG-n0tNP7Hh4efjwI3RK8FAyTR9j5pcCYYMbP0JxIytMMk-w8_oTiNJOUzNBVCDuMKS44vUQzWmApSU7n6PCxVcZDO7rQ2MaofeO7pHdjSKCrfDC-b0xiDsb5fuv33nhVj26ivmEIketPCJTzHSRNNA1Nq4ZD4nvoUtXVDpLaqdH4Vl2jC6tcgJvjXaCv5_Xn6jXdvL-8rZ42qWGU7lNTgCC5JEJmNldWWCZ5hY2oCsatUJpiS6w2HKRWNANdMFoxsDLXimspgS3Qw-Q1gw9hAFseR5UEl78ByxiwPAaM9N1E96Nuofpn_4pF4H4Cgqqh3Plx6OL6k64f41h9eQ</recordid><startdate>201803</startdate><enddate>201803</enddate><creator>Pérez Bartolomé, Francisco</creator><creator>Rodrigues, Ian A.</creator><creator>Goyal, Saurabh</creator><creator>Bloch, Edward</creator><creator>Lim, Wei S.</creator><creator>Alaghband, Pouya</creator><creator>Guajardo, Jose</creator><creator>Jones, Stephanie</creator><creator>Lim, Kin S.</creator><general>SAGE Publications</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201803</creationdate><title>Phacoemulsification plus endoscopic cyclophotocoagulation versus phacoemulsification alone in primary open-angle glaucoma</title><author>Pérez Bartolomé, Francisco ; Rodrigues, Ian A. ; Goyal, Saurabh ; Bloch, Edward ; Lim, Wei S. ; Alaghband, Pouya ; Guajardo, Jose ; Jones, Stephanie ; Lim, Kin S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c322t-c9e51871576f8af5f374d0c5d934f5ab20f1fbc4e7ba26eb932d3ef78ba4b77e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pérez Bartolomé, Francisco</creatorcontrib><creatorcontrib>Rodrigues, Ian A.</creatorcontrib><creatorcontrib>Goyal, Saurabh</creatorcontrib><creatorcontrib>Bloch, Edward</creatorcontrib><creatorcontrib>Lim, Wei S.</creatorcontrib><creatorcontrib>Alaghband, Pouya</creatorcontrib><creatorcontrib>Guajardo, Jose</creatorcontrib><creatorcontrib>Jones, Stephanie</creatorcontrib><creatorcontrib>Lim, Kin S.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><jtitle>European journal of ophthalmology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pérez Bartolomé, Francisco</au><au>Rodrigues, Ian A.</au><au>Goyal, Saurabh</au><au>Bloch, Edward</au><au>Lim, Wei S.</au><au>Alaghband, Pouya</au><au>Guajardo, Jose</au><au>Jones, Stephanie</au><au>Lim, Kin S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Phacoemulsification plus endoscopic cyclophotocoagulation versus phacoemulsification alone in primary open-angle glaucoma</atitle><jtitle>European journal of ophthalmology</jtitle><addtitle>Eur J Ophthalmol</addtitle><date>2018-03</date><risdate>2018</risdate><volume>28</volume><issue>2</issue><spage>168</spage><epage>174</epage><pages>168-174</pages><issn>1120-6721</issn><eissn>1724-6016</eissn><abstract>Purpose: To examine the efficacy and safety of combined phacoemulsification and endoscopic cyclophotocoagulation (phaco-ECP) compared to phacoemulsification alone in patients with primary open-angle glaucoma (POAG). Methods: We performed a retrospective notes review of 99 consecutive clinical records of patients with POAG from 2 London eye departments. A total of 69 patients who underwent phaco-ECP and 30 sex- and age-matched control patients who underwent cataract surgery alone were included. Data on intraocular pressure (IOP), visual acuity (VA), number of ocular hypotensive medications, and postoperative complications were collected over 12 months. The primary outcome measure was defined as an IOP within normal limits (&lt;21 mm Hg) and at least a 20% reduction in IOP from baseline. Results: Mean IOP was significantly decreased in both groups after 1 year (p&lt;0.001 from baseline). The success rate was significantly higher in the phaco-ECP group (69.6%) than in the phaco group (40%) after 1 year (p = 0.004). Reduction in mean IOP and number of medications was also greater in the phaco-ECP group after 1 year (IOP reduction: 4.5 ± 5.13 mm Hg vs 1.83 ± 3.61 mm Hg; p = 0.007; number of medications reduction: 0.73 ± 0.71 vs 0.23 ± 0.56; p = 0.001). Both groups achieved a similar improvement in VA. There was a higher incidence of minor and self-limiting complications in the phaco-ECP group (p&lt;0.047). Conclusions: Phaco-ECP resulted in a greater reduction in IOP and number of medications than phacoemulsification alone in POAG.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>29077182</pmid><doi>10.5301/ejo.5001034</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1120-6721
ispartof European journal of ophthalmology, 2018-03, Vol.28 (2), p.168-174
issn 1120-6721
1724-6016
language eng
recordid cdi_crossref_primary_10_5301_ejo_5001034
source Access via SAGE
title Phacoemulsification plus endoscopic cyclophotocoagulation versus phacoemulsification alone in primary open-angle glaucoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T02%3A56%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-sage_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Phacoemulsification%20plus%20endoscopic%20cyclophotocoagulation%20versus%20phacoemulsification%20alone%20in%20primary%20open-angle%20glaucoma&rft.jtitle=European%20journal%20of%20ophthalmology&rft.au=P%C3%A9rez%20Bartolom%C3%A9,%20Francisco&rft.date=2018-03&rft.volume=28&rft.issue=2&rft.spage=168&rft.epage=174&rft.pages=168-174&rft.issn=1120-6721&rft.eissn=1724-6016&rft_id=info:doi/10.5301/ejo.5001034&rft_dat=%3Csage_cross%3E10.5301_ejo.5001034%3C/sage_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/29077182&rft_sage_id=10.5301_ejo.5001034&rfr_iscdi=true